CARYX | GIPUX | CARYX / GIPUX | |
Total Expense Ratio | 0.77 | 0.61 | 126% |
Annual Report Gross Expense Ratio | 0.77 | 0.68 | 113% |
Fund Existence | 11 years | 10 years | - |
Gain YTD | 12.644 | 9.886 | 128% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000000 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.5B | 582M | 430% |
Annual Yield % from dividends | 2.28 | 4.20 | 54% |
Returns for 1 year | 10.78 | 9.32 | 116% |
Returns for 3 years | 34.65 | 37.57 | 92% |
Returns for 5 years | 11.47 | 25.74 | 45% |
Returns for 10 years | 37.20 | 59.26 | 63% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HELX | 33.01 | 0.58 | +1.80% |
Franklin Genomic Advancements ETF | |||
IBHE | 23.17 | 0.02 | +0.06% |
iShares iBonds 2025 Term HY and Inc ETF | |||
JHPI | 23.31 | N/A | N/A |
JHancock Preferred Income ETF | |||
NLR | 145.54 | -0.17 | -0.12% |
VanEck Uranium & Nuclear ETF | |||
RFIX | 42.40 | -0.52 | -1.21% |
Simplify Downside Interest Rate Hedge Strategy ETF |